SCHEMBL1109612

SCHEMBL1109612

O=C([O-])c1occc(=O)c1O.O=C([O-])c1occc(=O)c1O.O=[V+2]

nearest known ligand 0.63

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.47
LMNA P02545 1/20 0.47
MMP1 P03956 1/20 0.42
MMP3 P08254 1/20 0.42
MMP7 P09237 1/20 0.42
MMP9 P14780 1/20 0.42
MMP8 P22894 1/20 0.42
MMP12 P39900 1/20 0.42
MMP13 P45452 1/20 0.42
APP P05067 6/20 0.36
FTO Q9C0B1 2/20 0.34
MAPK1 P28482 1/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
DBH P09172 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3796160 0.98 KDM4E (0.48) KDM4ELMNAMMP1MMP3MMP7
SCHEMBL15287180 0.94 KDM4E (0.48) KDM4ELMNAMMP1MMP3MMP7
SCHEMBL356631 0.94 KDM4E (0.48) KDM4ELMNAMMP1MMP3MMP7
SCHEMBL25332706 0.76 KDM4E (0.55) KDM4ELMNAMMP1MMP3MMP7
SCHEMBL13947098 0.76 KDM4E (0.50) KDM4ELMNAMMP1MMP3MMP7
SCHEMBL146966 0.74 KDM4E (0.48) KDM4ELMNAMMP1MMP3MMP7
SCHEMBL23879785 0.72 KDM4E (0.50) KDM4ELMNAMMP1MMP3MMP7
SCHEMBL23879802 0.72 KDM4E (0.50) KDM4ELMNAMMP1MMP3MMP7
SCHEMBL23879799 0.72 KDM4E (0.50) KDM4ELMNAMMP1MMP3MMP7
SCHEMBL30501036 0.71 KDM4E (0.35) KDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023191112-A1 DENTAL CURABLE COMPOSITION HAVING FAVORABLE COLOR COMPATIBILITY クラレノリタケデンタル株式会社 2023-10-05 WO disclosed
EP-3937880-A1 PRIMER AND KIT CONSISTING OF THE PRIMER AND DENTAL MATERIAL Kettenbach GmbH & CO. KG (DE) 2022-01-19 EP disclosed
US-20210244519-A1 PHOTOCURABLE COMPOSITION, DENTURE RELINE MATERIAL, AND KIT FOR PREPARING THESE TOKUYAMA DENTAL CORPORATION (JP) 2021-08-12 US disclosed
EP-3854820-A1 PHOTOCURABLE COMPOSITION, DENTAL PLATE LINER, AND KIT FOR PREPARING THESE Tokuyama Dental Corporation (JP) 2021-07-28 EP disclosed
US-11033464-B2 Composition with excellent storage stability using highly basic filler SHOFU INC. (JP) 2021-06-15 US disclosed
WO-2020182918-A1 PRIMER AND KIT CONSISTING OF THE PRIMER AND DENTAL MATERIAL KETTENBACH GMBH & CO. KG (DE) 2020-09-17 WO disclosed
WO-2020067146-A1 RADICAL POLYMERIZABLE SILANE COUPLING COMPOUND HAVING URETHANE BOND AND USING DIISOCYANATE AS SUBSTRATE 株式会社松風 2020-04-02 WO disclosed
WO-2020059399-A1 PHOTOCURABLE COMPOSITION, DENTAL PLATE LINER, AND KIT FOR PREPARING THESE 株式会社トクヤマデンタル 2020-03-26 WO disclosed
WO-2020031897-A1 POLYMERIZATION INITIATOR, CURABLE COMPOSITION, DENTAL MATERIAL, AND PREPARATION KIT FOR CURABLE COMPOSITION 三井化学株式会社 2020-02-13 WO disclosed
WO-2019203356-A1 ADHESIVE COMPOSITION FOR DENTAL USE クラレノリタケデンタル株式会社 2019-10-24 WO disclosed
WO-2019172132-A1 PACKAGED DENTAL COMPOSITION, METHOD FOR MANUFACTURING SAME AND DENTAL COMPOSITION 株式会社トクヤマデンタル 2019-09-12 WO disclosed
US-20190262238-A1 COMPOSITION WITH EXCELLENT STORAGE STABILITY USING HIGHLY BASIC FILLER SHOFU INC. (JP) 2019-08-29 US disclosed
EP-2280032-B1 PHOTOPOLYMERIZABLE COMPOSITIONS TOKUYAMA DENTAL CORP (JP) 2015-01-07 EP disclosed
US-8394869-B2 Photopolymerizable compositions useful as a dental restorative material TOKUYAMA DENTAL CORPORATION (JP) 2013-03-12 US disclosed
US-20110172323-A1 PHOTOPOLYMERIZABLE COMPOSITIONS TOKUYAMA DENTAL CORPORATION (JP) 2011-07-14 US disclosed
EP-2280032-A1 PHOTOPOLYMERIZABLE COMPOSITIONS Tokuyama Dental Corporation (JP) 2011-02-02 EP disclosed
EP-0740551-A1 VANADATE COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS, METASTASES AND DRUG RESISTANT TUMORS MOUNT SINAI HOSPITAL CORPORATION (CA) 1996-11-06 EP disclosed
WO-1995019177-A1 VANADATE COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS, METASTASES AND DRUG RESISTANT TUMORS MOUNT SINAI HOSPITAL CORPORATION (CA) 1995-07-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172323-A1 PHOTOPOLYMERIZABLE COMPOSITIONS RARA, RARB, RARG KDM4E 438/4885LMNA 586/4885MMP1 2889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.